Insights On Pharmaceutical Logistics

31. Shedding Light On Photo-Stability Forced Degradation 11/26/2024

    Ensure the stability and safety of your drug products by utilizing comprehensive forced degradation and photo-stability testing, guided by ICH and FDA standards, to identify degradation pathways and assess light exposure risks.

32. How To Select The Right Fill-Finish CDMO For Phase I–II 3/16/2026

    Early‑phase programs require flexible, technically aligned fill‑finish partners. Mid‑sized CDMOs offer a balance of agility, infrastructure, and regulatory maturity suited to Phase I–II needs.

33. Stick-Pack Benefits For Pharmaceuticals And Nutraceuticals 10/24/2024

    Explore the key advantages of stick-pack formats for pharmaceuticals and nutraceuticals, from enhanced product safety and cost-efficiency to improved compliance and marketability.

34. Quality Roundtable: Raw Material Planning For Tech Transfer And Scaling Biologics 1/22/2025

    Join this roundtable of biopharmaceutical professionals as they share their insights to help you navigate important quality and planning decisions for the progression of your biologic.

35. The Future Of RNA Manufacturing Starts With Raw Material Innovation 2/11/2026

    Amid the mRNA and oligonucleotide therapeutic boom, sponsors and manufacturers are exploring how to make critical raw materials—capping agents, lipid nanoparticles, and RNA polymerase—more effective.

36. Empowering Patients With Self-Administration Drug Delivery Devices 8/16/2025

    Discover how these devices offer solutions to the challenges of precise dosing, patient compliance, retention, and safety, uplifting the overall trial experience and providing real world insights.

37. Clinical, Commercial Packaging: Delivering Next-Gen Therapies 4/7/2026

    See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.

38. How To Save Significantly On Early-Phase Clinical Supply 5/6/2026

    Discover how integrated clinical supply strategies streamline early trials, reduce logistics complexity, cut costs, and ensure timely delivery of investigational products and samples.

39. Building A Purification Toolkit For An Expanding Variety Of mAb Therapeutics 5/29/2025

    Explore techniques for optimizing purification toolkits for various monoclonal antibody formats. This session covers resin and buffer selection for efficient downstream process development.

40. A Temperature-Stable Replacement For Animal Trypsin In Cell Dissociation Applications 6/9/2025

    Improve cell dissociation with a gentle, recombinant enzyme. This temperature-stable protease shows dissociation kinetics similar to porcine trypsin but with lower cell toxicity and greater overall purity.